Anna Dobrzeniecka
Warsaw, MZ, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
The impact of pediatric influenza and COVID-19 hospitalization on parental attitudes toward vaccination.
Journal: Human vaccines & immunotherapeutics
Published: June 05, 2026
Autoimmune Hepatitis After Successful Treatment of Chronic Hepatitis C Virus Infection with Direct-Acting Antivirals: A Pediatric Case Report.
Journal: Pathogens (Basel, Switzerland)
Published: October 31, 2025
Comparison of Noninvasive Methods for the Evaluation of Liver Fibrosis in Children With Chronic Hepatitis C Virus Infection.
Journal: The Pediatric infectious disease journal
Published: September 18, 2025
To treat or not to treat young children with hepatitis C?--real-life experience.
Journal: European journal of pediatrics
Published: August 09, 2025
Efficacy and safety of sofosbuvir-based therapies for treating HCV in children: observations from a real-world setting.
Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Published: July 14, 2025
Glecaprevir/pibrentasvir in patients aged 3-17 years with chronic hepatitis C: Real-life data from the POLAC project.
Journal: Journal of pediatric gastroenterology and nutrition
Published: June 11, 2025
Health-related Quality of Life in Children and Adolescents After Successful Treatment of Chronic Hepatitis C With Sofosbuvir/Velpatasvir: One-year Outcomes.
Journal: The Pediatric infectious disease journal
Published: January 08, 2025
The Influence of Treatment With Sofosbuvir/Velpatasvir on Children's Growth-Results of the PANDAA-PED Study.
Journal: The Pediatric infectious disease journal
Published: September 04, 2024
Changes in liver stiffness and steatosis in children after successful treatment with sofosbuvir/velpatasvir: Results of the PANDAA-PED study.
Journal: Clinical and experimental hepatology
Published: July 03, 2024
Differences in Clinical Presentation of COVID-19 in Children Hospitalized During Domination of Early (BA.1, BA.2) and Late (BA.5, BA.2.75, BQ.1 and XBB.1.5) SARS-CoV-2 Omicron Subvariants.
Journal: The Pediatric infectious disease journal
Published: November 03, 2023
Health-related quality of life in patients aged 6-18 years with chronic hepatitis C treated with sofosbuvir/velpatasvir.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: August 01, 2023
Efficacy and safety of treatment with sofosbuvir/velpatasvir in patients aged 6-18 years with chronic hepatitis C-Results of the PANDAA-PED study.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: March 15, 2023
Last Updated: 09/26/2026